Evidence map›Paper›PMID 34257556›Full record

ArticlePathology oncology research : POR2021

Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study.

Sarah Adel Hakim, Hoda Hassan Abou Gabal

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sarah Adel HakimDepartment of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Hoda Hassan Abou GabalDepartment of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Ain Shams University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedBiomarkers, TumorDiagnosis, DifferentialEnhancer of Zeste Homolog 2 ProteinFemaleFollow-Up StudiesHumansHyperplasiaMaleMesothelioma, MalignantMiddle AgedPleural NeoplasmsPrognosisRetrospective StudiesSurvivinTumor Suppressor ProteinsBAP1 protein, humanBiomarkers, TumorBIRC5 protein, humanEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanSurvivinTumor Suppressor ProteinsUbiquitin ThiolesteraseBAP1EZH2immunohistochemistrymesotheliomareactive mesothelial hyperplasiasurvivin

Identifiers

PMID34257556
PMCPMC8262140
OpenAlexW3155915574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.